Cargando…
Attractor – a new turning point in drug discovery
Drug discovery for complex diseases can be viewed as a challenging problem in which the influence of compounds on dynamic features of disease system should be considered, especially the strategies escaping from the disease attractors. Moreover, escaping from the disease-related attractors has been p...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709805/ https://www.ncbi.nlm.nih.gov/pubmed/31686779 http://dx.doi.org/10.2147/DDDT.S216397 |
_version_ | 1783446244749737984 |
---|---|
author | Hou, Xucan Li, Meng Jia, Congmin Zhang, Xianbao Wang, Yun |
author_facet | Hou, Xucan Li, Meng Jia, Congmin Zhang, Xianbao Wang, Yun |
author_sort | Hou, Xucan |
collection | PubMed |
description | Drug discovery for complex diseases can be viewed as a challenging problem in which the influence of compounds on dynamic features of disease system should be considered, especially the strategies escaping from the disease attractors. Moreover, escaping from the disease-related attractors has been proved to be a cue for the treatment of the complex diseases. The drug discovery methodology based on the attractor theory indicates new solutions for target identification, drug discovery and drug combination design. The methodology is based on the holism level of the organism and the features of system dynamics, so it has advantages for the classification of complex diseases and drug discovery. Currently, research results of this method have increased, which expand the insight scope for drug discovery. This article introduces the major drug discovery methods in the history of pharmacy development and their characteristics, so as to illustrate the reasons and inevitability of the appearance of attractor method, its position in the history of pharmacy development, and its advantages for drug discovery and design, thereby to prove that the attractor method can indeed become the next major drug development method. In addition, it provides a comprehensive description about the concept of attractor, the pipeline of attractor analysis, the common methods of each process and its research progress, so as to provide a macroscopic framework and optional methods and tools for the follow-up researchers. |
format | Online Article Text |
id | pubmed-6709805 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-67098052019-11-04 Attractor – a new turning point in drug discovery Hou, Xucan Li, Meng Jia, Congmin Zhang, Xianbao Wang, Yun Drug Des Devel Ther Review Drug discovery for complex diseases can be viewed as a challenging problem in which the influence of compounds on dynamic features of disease system should be considered, especially the strategies escaping from the disease attractors. Moreover, escaping from the disease-related attractors has been proved to be a cue for the treatment of the complex diseases. The drug discovery methodology based on the attractor theory indicates new solutions for target identification, drug discovery and drug combination design. The methodology is based on the holism level of the organism and the features of system dynamics, so it has advantages for the classification of complex diseases and drug discovery. Currently, research results of this method have increased, which expand the insight scope for drug discovery. This article introduces the major drug discovery methods in the history of pharmacy development and their characteristics, so as to illustrate the reasons and inevitability of the appearance of attractor method, its position in the history of pharmacy development, and its advantages for drug discovery and design, thereby to prove that the attractor method can indeed become the next major drug development method. In addition, it provides a comprehensive description about the concept of attractor, the pipeline of attractor analysis, the common methods of each process and its research progress, so as to provide a macroscopic framework and optional methods and tools for the follow-up researchers. Dove 2019-08-22 /pmc/articles/PMC6709805/ /pubmed/31686779 http://dx.doi.org/10.2147/DDDT.S216397 Text en © 2019 Hou et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Hou, Xucan Li, Meng Jia, Congmin Zhang, Xianbao Wang, Yun Attractor – a new turning point in drug discovery |
title | Attractor – a new turning point in drug discovery |
title_full | Attractor – a new turning point in drug discovery |
title_fullStr | Attractor – a new turning point in drug discovery |
title_full_unstemmed | Attractor – a new turning point in drug discovery |
title_short | Attractor – a new turning point in drug discovery |
title_sort | attractor – a new turning point in drug discovery |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709805/ https://www.ncbi.nlm.nih.gov/pubmed/31686779 http://dx.doi.org/10.2147/DDDT.S216397 |
work_keys_str_mv | AT houxucan attractoranewturningpointindrugdiscovery AT limeng attractoranewturningpointindrugdiscovery AT jiacongmin attractoranewturningpointindrugdiscovery AT zhangxianbao attractoranewturningpointindrugdiscovery AT wangyun attractoranewturningpointindrugdiscovery |